← Scroll for more →
Rani Therapeutics Holdings, Inc. (RANI)
Pharmaceutical Preparations
Latest Price
$0.59
TTM P/E
--
Normalized P/E
--
TTM Div Yield
--
Fwd Div Yield
--
Book Value
0.22
P/B Ratio
2.71
Institutional Ownership
23.9% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Samsara Biocapital, LLC | 10.37M | $7.0M | 5.54% | +1.87M | 2026-06-30 |
| RA Capital Management, L.P. | 8.50M | $6.0M | 4.54% | -- | 2026-06-30 |
| AWM Investment Company, Inc. | 7.50M | $5.0M | 4.01% | +1.00M | 2026-06-30 |
| Vanguard Capital Management LLC | 4.56M | $3.0M | 2.44% | -59.6K | 2026-06-30 |
| Longaeva Partners L.P. | 2.33M | $1.0M | 1.24% | -- | 2026-06-30 |
| Polar Asset Management Partners Inc. | 2.32M | $1.0M | 1.24% | -- | 2026-06-30 |
| Siren, L.L.C. | 2.00M | $1.0M | 1.07% | -- | 2026-06-30 |
| Geode Capital Management, LLC | 890.6K | -- | 0.48% | -12.7K | 2026-06-30 |
| Citadel Advisors LLC | 657.8K | -- | 0.35% | +381.2K | 2026-06-30 |
| Marshall Wace, LLP | 586.3K | -- | 0.31% | -- | 2026-06-30 |